
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
1 September 2009:
Press Release no. 4, 2009: Zealand Pharma advances a new generation of Type 2 Diabetes treatment
15 May 2009:
Press Release no.3, 2009: Zealand Pharma A/S to highlight importance of partnering in diabetes care at 2009 BIO International Convention, Atlanta, USA
18 March 2009:
Press Release no.2, 2009: Zealand Pharma A/S receives Frost & Sullivan 2008 European Research & Development Award
3 February 2009:
Press Release no. 1, 2009: Zealand Pharma A/S advances ZP1848 for the prevention and treatment of Inflammatory Bowel Disease into Phase I clinical trials
Home Legal Disclaimer Updated: 27.7.2010